Aethlon Medical, Inc.
$2.39
▼
-1.4%
2026-04-21 05:06:02
www.aethlonmedical.com
NCM: AEMD
Explore Aethlon Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.67 M
Current Price
$2.39
52W High / Low
$35.2 / $1.36
Stock P/E
—
Book Value
$6.9
Dividend Yield
—
ROCE
-171.08%
ROE
-2.09%
Face Value
—
EPS
$-48.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
9
Beta
1.52
Debt / Equity
6.22
Current Ratio
5.68
Quick Ratio
3.13
Forward P/E
-2.21
Price / Sales
—
Enterprise Value
$-3.69 M
EV / EBITDA
0.53
EV / Revenue
—
Rating
None
Target Price
$4.75
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 2. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 3. | Intelligent Bio Solutions Inc. | $2.93 | — | $5.86 M | — | -359.62% | -1.5% | $24.9 / $2.42 | $8.96 |
| 4. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
| 5. | Sensus Healthcare, Inc. | $4.06 | — | $66.84 M | — | -21.33% | -14.85% | $5.92 / $3.03 | $1.57 |
| 6. | RxSight, Inc. | $7.44 | — | $314.04 M | — | -16.88% | -13.98% | $16.74 / $5.9 | $6.68 |
| 7. | 908 Devices Inc. | $7.3 | 13.73 | $267.64 M | — | -16.46% | -25.77% | $9.34 / $4.2 | $3.96 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -2.06 M | -1.51 M | -1.79 M | -2 M | -1.81 M | — |
| Net Profit | -2.02 M | -1.49 M | -1.76 M | -6.25 M | -1.75 M | — |
| EPS in Rs | -1.29 | -0.95 | -1.12 | -3.99 | -1.12 | -16 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0.57 M | 0.29 M |
| Operating Profit | -9.34 M | -12.64 M | -11.9 M | -10.42 M |
| Net Profit | -13.39 M | -12.21 M | -12.03 M | -10.42 M |
| EPS in Rs | -8.53 | -7.78 | -7.67 | -6.64 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.36 M | 8.25 M | 17.51 M | 19.42 M |
| Total Liabilities | 2.24 M | 2.48 M | 2.44 M | 2.43 M |
| Equity | 5.12 M | 5.77 M | 15.06 M | 17.13 M |
| Current Assets | 5.95 M | 6.23 M | 15.09 M | 18.16 M |
| Current Liabilities | 1.9 M | 1.83 M | 1.51 M | 1.82 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.65 M | -10.13 M | -10.51 M | -9.77 M |
| Investing CF | 0 M | -0.25 M | -0.94 M | -0.35 M |
| Financing CF | 7.73 M | 1.29 M | 8.91 M | 17.37 M |
| Free CF | -7.65 M | -10.38 M | -11.45 M | -10.12 M |
| Capex | — | -0.25 M | -0.94 M | -0.35 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | -100% | 95.21% | — |
| Earnings Growth % | -9.66% | -1.48% | -15.49% | — |
| Profit Margin % | — | — | -2094.89% | -3540.9% |
| Operating Margin % | — | — | -2072.05% | -3542.53% |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | -2030.1% | -3500.48% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-10-20 | 1:0.1 |
| 2025-06-09 | 1:0.125 |
| 2023-10-05 | 1:0.1 |